Literature DB >> 15930755

Aldose reductase inhibitors from the fruiting bodies of Ganoderma applanatum.

Sanghyun Lee1, Sang Hee Shim, Ju Sun Kim, Kuk Hyun Shin, Sam Sik Kang.   

Abstract

The isolation and characterization of rat lens aldose reductase (RLAR) inhibitors from the fruiting bodies of Ganoderma applanatum were conducted. Among the extracts and fractions from G. applanatum tested, the MeOH extract and EtOAc fraction were found to exhibit potent RLAR inhibition in vitro, their IC50 being 1.7 and 0.8 microg/ml, respectively. From the active EtOAc fraction, seven compounds with diverse structural moieties were isolated and identified as D-mannitol (1), 2-methoxyfatty acids (2), cerebrosides (3), daucosterol (4), 2,5-dihydroxyacetophenone (5), 2,5-dihydroxybenzoic acid (6), and protocatechualdehyde (7). Among them, protocatechualdehyde (7) was found to be the most potent RLAR inhibitor (IC50=0.7 microg/ml), and may be useful for the prevention and/or treatment of diabetic complications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930755     DOI: 10.1248/bpb.28.1103

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  10 in total

1.  Identification of novel alpha-methoxylated phospholipid fatty acids in the Caribbean sponge Erylus goffrilleri.

Authors:  Néstor M Carballeira; Delise Oyola; Jan Vicente; Abimael D Rodriguez
Journal:  Lipids       Date:  2007-08-21       Impact factor: 1.880

2.  Pharmacological modulation of histone demethylase activity by a small molecule isolated from subcritical water extracts of Sasa senanensis leaves prolongs the lifespan of Drosophila melanogaster.

Authors:  Yuzo Nakagawa-Yagi; Yukiko Sato; Emi Matsumoto; Shin-Ichi Nakatsuka; Tsuyoshi Sakaki; Yukiko Muramatsu; Takaaki Hara; Toshiro Aigaki
Journal:  BMC Complement Altern Med       Date:  2012-07-18       Impact factor: 3.659

3.  Hypouricemic Effect of 2,5-Dihydroxyacetophenone, a Computational Screened Bioactive Compound from Ganoderma applanatum, on Hyperuricemic Mice.

Authors:  Danling Liang; Tianqiao Yong; Shaodan Chen; Yizhen Xie; Diling Chen; Xinxin Zhou; Dan Li; Muxia Li; Lu Su; Dan Zuo
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

4.  Evaluation of the Therapeutic Effects of Protocatechuic Aldehyde in Diabetic Nephropathy.

Authors:  Yu-Teng Chang; Mu-Chi Chung; Chang-Chi Hsieh; Jeng-Jer Shieh; Ming-Ju Wu
Journal:  Toxins (Basel)       Date:  2021-08-10       Impact factor: 4.546

5.  Anti-EMT and anti-fibrosis effects of protocatechuic aldehyde in renal proximal tubular cells and the unilateral ureteral obstruction animal model.

Authors:  Yu-Teng Chang; Mu-Chi Chung; Chi-Hao Chang; Kuan-Hsun Chiu; Jeng-Jer Shieh; Ming-Ju Wu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

Review 6.  Advances in pharmacological strategies for the prevention of cataract development.

Authors:  S K Gupta; V Kalai Selvan; S S Agrawal; Rohit Saxena
Journal:  Indian J Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.848

Review 7.  Meroterpenoids from Ganoderma Species: A Review of Last Five Years.

Authors:  Xingrong Peng; Minghua Qiu
Journal:  Nat Prod Bioprospect       Date:  2018-05-02

8.  Evaluation of the Antibacterial Effects and Mechanism of Action of Protocatechualdehyde against Ralstonia solanacearum.

Authors:  Shili Li; Yanmei Yu; Juanni Chen; Bing Guo; Liang Yang; Wei Ding
Journal:  Molecules       Date:  2016-06-09       Impact factor: 4.411

9.  Antimicrobial and antioxidative activities of bioactive constituents from Hydnophytum formicarum Jack.

Authors:  Supaluk Prachayasittikul; Prasit Buraparuangsang; Apilak Worachartcheewan; Chartchalerm Isarankura-Na-Ayudhya; Somsak Ruchirawat; Virapong Prachayasittikul
Journal:  Molecules       Date:  2008-04-18       Impact factor: 4.411

Review 10.  Mushrooms of the Genus Ganoderma Used to Treat Diabetes and Insulin Resistance.

Authors:  Katarzyna Wińska; Wanda Mączka; Klaudia Gabryelska; Małgorzata Grabarczyk
Journal:  Molecules       Date:  2019-11-11       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.